Everest Re Group (NYSE:RE)‘s stock had its “buy” rating reaffirmed by equities researchers at Barclays in a note issued to investors on Sunday. They presently have a $290.00 price target on the insurance provider’s stock. Barclays’ price objective would indicate a potential upside of 19.21% from the stock’s previous close.
A number of other equities analysts have also weighed in on the stock. Zacks Investment Research upgraded shares of Everest Re Group from a “hold” rating to a “strong-buy” rating and set a $253.00 price target for the company in a research report on Friday, January 5th. Wells Fargo & Co reiterated a “market perform” rating and issued a $235.00 price target (down from $240.00) on shares of Everest Re Group in a research report on Tuesday, January 9th. Keefe, Bruyette & Woods upgraded shares of Everest Re Group from an “underperform” rating to a “market perform” rating in a research report on Monday, November 27th. UBS Group upped their price target on shares of Everest Re Group from $230.00 to $245.00 and gave the stock a “neutral” rating in a research report on Monday, November 6th. Finally, TheStreet upgraded shares of Everest Re Group from a “c+” rating to a “b-” rating in a research report on Monday, January 22nd. Eight investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Everest Re Group has a consensus rating of “Hold” and a consensus target price of $254.13.
Shares of Everest Re Group (NYSE RE) opened at $243.26 on Friday. The company has a current ratio of 0.31, a quick ratio of 0.33 and a debt-to-equity ratio of 0.08. The stock has a market cap of $9,933.76, a P/E ratio of 21.84, a P/E/G ratio of 1.13 and a beta of 0.59. Everest Re Group has a 12-month low of $208.81 and a 12-month high of $277.17.
In related news, Director John A. Graf bought 2,285 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The stock was purchased at an average price of $219.07 per share, for a total transaction of $500,574.95. Following the completion of the transaction, the director now owns 5,550 shares in the company, valued at $1,215,838.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.
Large investors have recently modified their holdings of the stock. Focused Wealth Management Inc bought a new position in shares of Everest Re Group during the fourth quarter worth $111,000. Valeo Financial Advisors LLC bought a new position in shares of Everest Re Group during the third quarter worth $137,000. Cerebellum GP LLC bought a new position in shares of Everest Re Group during the fourth quarter worth $133,000. Tower Research Capital LLC TRC bought a new position in shares of Everest Re Group during the fourth quarter worth $144,000. Finally, Fuller & Thaler Asset Management Inc. boosted its position in shares of Everest Re Group by 87.5% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 750 shares of the insurance provider’s stock worth $166,000 after acquiring an additional 350 shares during the last quarter. Hedge funds and other institutional investors own 92.14% of the company’s stock.
Everest Re Group Company Profile
Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies.
Receive News & Ratings for Everest Re Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group and related companies with MarketBeat.com's FREE daily email newsletter.